APT(SH:688617) Sou Hu Cai Jing·2025-09-13 19:31Core Viewpoint - Huatai Medical (688617) experienced a decline in stock price, closing at 300.08 CNY, down 3.02% from the previous week, with a market capitalization of 42.808 billion CNY, ranking 4th in the medical device sector [1] Trading Information Summary - On September 11, Huatai Medical executed a block trade at a discount of 19.81%, with a total transaction amount of 537 million CNY [2][6] Shareholder Changes - On September 11, Shenzhen Mindray Technology Holdings Co., Ltd. increased its stake in Huatai Medical by 2,164,739 shares, representing 1.54% of the total share capital, raising its total holding to 26.54% [3][5] - The same day, company director Cheng Zhenghui reduced his holdings by 2,820,275 shares, accounting for 2% of the total share capital, with a total transaction value of approximately 700 million CNY [4][6] Executive Changes - During the period of Cheng Zhenghui's share reduction, the company's stock price increased by 1.21%, closing at 309.53 CNY on the day of the transaction [4][6] Company Announcements - Huatai Medical will participate in a collective performance briefing for the medical device industry on September 17, 2025, to discuss its semi-annual operating results and financial status [4][6]